Research programme: NF-kappa B inhibitors - 4SC
Alternative Names: 4SC-102; 4SC-301; SC 71492; SC 71570; SC 75741Latest Information Update: 09 Oct 2013
At a glance
- Originator 4SC
- Class Small molecules
- Mechanism of Action NF-kappa B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Cancer; Inflammation
Highest Development Phases
- Discontinued Cancer; Hepatitis C; Inflammation; Inflammatory bowel diseases; Rheumatoid arthritis; Viral infections
Most Recent Events
- 08 Aug 2013 Discontinued - Preclinical for Cancer in Germany (unspecified route)
- 08 Aug 2013 Discontinued - Preclinical for Hepatitis C in Germany (unspecified route)
- 08 Aug 2013 Discontinued - Preclinical for Inflammation in Germany (PO)